Suberoyl Bishydroxamic Acid Activates Notch1 Signaling and Suppresses Tumor Progression in an Animal Model of Medullary Thyroid Carcinoma
- 18 June 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 15 (9) , 2600-2605
- https://doi.org/10.1245/s10434-008-0006-z
Abstract
Background Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that frequently metastasizes and has few treatments. This study was aimed at assessing the antitumor effects of suberoyl...Keywords
This publication has 20 references indexed in Scilit:
- Current Management of Medullary Thyroid CancerThe Oncologist, 2008
- Suberoyl Bis-Hydroxamic Acid Activates Notch-1 Signaling and Induces Apoptosis in Medullary Thyroid Carcinoma CellsThe Oncologist, 2008
- Suberoyl Bishydroxamic Acid Inhibits Cellular Proliferation by Inducing Cell Cycle Arrest in Carcinoid Cancer CellsJournal of Gastrointestinal Surgery, 2007
- Medullary Thyroid Cancer: A Retrospective Analysis of a Cohort Treated at a Single Tertiary Care Center Between 1970 and 2005Thyroid®, 2007
- Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid CancerAsian Journal of Surgery, 2007
- Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cellsApoptosis, 2006
- Sensitization of mesothelioma to TRAIL apoptosis by inhibition of histone deacetylase: role of Bcl-xL down-regulationBiochemical and Biophysical Research Communications, 2004
- Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Histone Acetylation Modifiers in the Pathogenesis of Malignant DiseaseMolecular Medicine, 2000
- Effective Long-term Palliation of Symptomatic, Incurable Metastatic Medullary Thyroid Cancer by Operative ResectionAnnals of Surgery, 1998